Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers
Date
2013
Authors
Welldon, K.
Findlay, D.
Evdokiou, A.
Ormsby, R.
Atkins, G.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Molecular and Cellular Endocrinology, 2013; 376(1):85-92
Statement of Responsibility
Katie J. Welldon, David M. Findlay, Andreas Evdokiou, Renee T. Ormsby, Gerald J. Atkins
Conference Name
Abstract
Calcium, in combination with vitamin D, is an effective treatment for osteoporosis. Since bone mineralisation occurs concurrently with osteoblast to osteocyte transition, we hypothesised that calcium would stimulate this process. The effect of calcium (1.8-11.8mM) was tested on human primary osteoblast (NHBC) differentiation in vitro. Cultures were assayed for cell-associated mineral and gene expression associated with osteoblast differentiation and mineralisation. Treatment with calcium resulted in a striking dose- and time-dependent increase in cell-associated mineralisation. Calcium appeared to promote osteoblast to osteocyte differentiation, as indicated by increased expression of osteocalcin (OCN), E11, dentin matrix protein 1 (DMP1) and SOST mRNA. The expression of the osteoclast inhibitor, osteoprotegerin, was dramatically enhanced by calcium. Calcium also increased the ratio of PHEX mRNA expression relative to that of MEPE, suggesting a mechanism for the pro-anabolic effect. Consistent with this, calcium-dependent mineralisation was reversed in the presence of MEPE-ASARM peptides. This study suggests that calcium promotes osteoblast to osteocyte transition and concurrent matrix mineralisation, at least in part through the PHEX-MEPE axis.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.